Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Chooses Lark's In-House Service Lab

Premium

HOUSTON--Lark Technologies has finalized an agreement with Pfizer to establish an in-house contract service laboratory focused on providing high-quality, fast-turnaround DNA sequencing services for Pfizer. Lark will provide the services in a laboratory exclusively dedicated to meeting the DNA sequencing requests of Pfizer at its UK facility in Sandwich.

Lark will work on behalf of Pfizer for specified fees on a no-rights-retained, contract basis. Lark said the deal is attractive for companies like Pfizer that have multiple project needs and require a consistent and reliable flow of high-quality DNA sequence information.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.